Guarini Kathryn: insider trades.
Guarini Kathryn reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($660K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Guarini Kathryn
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | Director | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Regeneron Pharmaceuticals, Inc. | M | 400 | $719.37 | 1,003 | Form 4 |
| 2026-09-02 | Regeneron Pharmaceuticals, Inc. | S | 400 | $850 | 603 | Form 4 |
| 2026-08-10 | Regeneron Pharmaceuticals, Inc. | S | 400 | $800 | 603 | Form 4 |
| 2026-08-10 | Regeneron Pharmaceuticals, Inc. | M | 400 | $719.37 | 1,003 | Form 4 |
Questions
What stock did Guarini Kathryn buy or sell?
Guarini Kathryn reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($660K), across 1 company.
Is Guarini Kathryn the same person as other filers with this name?
This page covers SEC CIK 1992352 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/guarini-kathryn-1992352.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.